Journal
EUROPEAN HEART JOURNAL
Volume 29, Issue 13, Pages 1681-1687Publisher
OXFORD UNIV PRESS
DOI: 10.1093/eurheartj/ehn215
Keywords
Fontan; cardiac output; oxygen uptake; exercise
Categories
Ask authors/readers for more resources
Aims We sought to assess the effects of sildenafil on exercise capacity and haemodynamic response to exercise in Fontan patients. Methods and results We prospectively studied 27 patients with Fontan circulation (age 22.8 +/- 4.9 years). All patients underwent a base-line exercise test with non-invasive measurement of cardiac index (CI) and pulmonary blood flow (PBF) index, and peak exercise oxygen uptake (VO2). After the baseline test, patients were randomly assigned to receive either a single 0.7 mg/kg body weight oral dose of sildenafil citrate (n = 18) or no treatment (control group, n = 9). After 1 h of rest, all patients performed a second exercise test. All patients completed the study protocol. The dose of sildenafil ranged from 25 to 50 mg. The change in peak VO2, the primary endpoint, was greater in the sildenafil group (9.4 +/- 5.2%) than in the control group (0.3 +/- 4.1%, P < 0.05). Sitdenafit increased rest and peak exercise PBF index (P < 0.01 and P < 0.05 vs. control group, respectively), as welt as rest and peak exercise Cl (P < 0.001 and P < 0.05 vs. control group, respectively), without altering rest or peak exercise transcutaneous arterial blood oxygen saturations (P > 0.05 vs. control group for both). No patient reported serious adverse events after sildenafil. Conclusion In Fontan patients, oral administration of a single dose of sildenafil improves exercise capacity and haemodynamic response to exercise.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available